Repros Therapeutics Inc Stock

Stocks

18-01-26	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
17-12-15	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
17-12-12	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-12-12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
17-12-12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

15-04-02	Apple : Les valeurs à suivre sur les marchés américains
15-04-02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+0.96%	+1.94%	-12.97%	-13.01%	43.03B
REVOLUTION MEDICINES, INC.	+4.02%	+7.26%	+294.33%	+533.90%	32.71B
IQVIA HOLDINGS INC.	-1.69%	-2.76%	+13.70%	-16.14%	30.29B
BEONE MEDICINES AG	+1.41%	-0.70%	-0.53%	+28.87%	29.4B
CELLTRION, INC.	+1.16%	+2.10%	+14.27%	+22.05%	25.08B
ASCENDIS PHARMA A/S	+2.40%	+6.10%	-	-	13.54B
MEDPACE HOLDINGS, INC.	+0.03%	+2.92%	+56.75%	+114.15%	13.35B
EUROFINS SCIENTIFIC SE	-1.09%	-2.37%	+5.07%	+5.25%	12.97B
IONIS PHARMACEUTICALS, INC.	+0.93%	-0.70%	+107.81%	+81.19%	12.11B
Average	+0.81%	+0.83%	+59.80%	+94.53%	23.61B
Weighted average by Cap.	+1.05%	+0.82%	+60.10%	+102.52%